SCHEMBL28201656

SCHEMBL28201656

Cc1ccc(C(N)=O)cn1.N#CF

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NNMT P40261 4/20 0.50
▸ HDAC1 Q13547 1/20 0.50
▸ HDAC6 Q9UBN7 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ GABRA1 P14867 1/20 0.43
▸ GRM5 P41594 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ F7 P08709 1/20 0.42
▸ F3 P13726 1/20 0.42
▸ SARM1 Q6SZW1 1/20 0.42
▸ SIRT2 Q8IXJ6 1/20 0.42
▸ SIRT6 Q8N6T7 1/20 0.42
▸ SIRT1 Q96EB6 1/20 0.42
▸ SIRT3 Q9NTG7 1/20 0.42
▸ SIRT5 Q9NXA8 1/20 0.42
▸ SIRT4 Q9Y6E7 1/20 0.42
▸ HPGDS O60760 1/20 0.41
▸ MKNK1 Q9BUB5 1/20 0.41
▸ MKNK2 Q9HBH9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28176950 0.90 NNMT (0.50) NNMTHDAC1HDAC6SMN1; SMN2GABRA1
SCHEMBL351856 0.89 NNMT (0.61) NNMTHDAC1HDAC6SMN1; SMN2GABRA1
SCHEMBL30231615 0.89 NNMT (0.61) NNMTHDAC1HDAC6SMN1; SMN2GABRA1
SCHEMBL30303086 0.77 HDAC1 (0.55) NNMTHDAC1HDAC6SMN1; SMN2GABRA1
SCHEMBL8018191 0.74 HDAC1 (0.60) HDAC1HDAC6SMN1; SMN2GRM5KDM4E
SCHEMBL1857619 0.73 HDAC1 (0.47) HDAC1HDAC6SMN1; SMN2KDM4EL3MBTL1
SCHEMBL4400941 0.73 HDAC1 (0.64) HDAC1HDAC6SMN1; SMN2KDM4ELMNA
SCHEMBL1993840 0.73 GRM5 (0.58) NNMTSMN1; SMN2GRM5KDM4EL3MBTL1
SCHEMBL30074957 0.72 HDAC1 (0.50) HDAC1HDAC6SMN1; SMN2GABRA1KDM4E
SCHEMBL1856776 0.72 HDAC1 (0.50) HDAC1HDAC6SMN1; SMN2GABRA1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104812762-B Substituted cyclic pyrimidin and triazine and their purposes 拜耳药业股份公司 2018-01-16 — — CN disclosed
Send feedback